Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
17 /100
LOW RISK
Score updated Aug 28, 2026

HIMS — Hims & Hers Health, Inc. Dilution Risk Tracker

Track HIMS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track HIMS — Get alerts when the score changes →

As of August 28, 2026, Hims & Hers Health, Inc. (HIMS) has a DilutionWatch DilutionScore of 17/100, rated LOW dilution risk. Hims & Hers Health, Inc. has a market capitalization of $6.05B, 223.08M shares outstanding, 445 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
25
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for HIMS.
🔔 Track HIMS — Get forecast alerts →

Market Data

Market Cap$6.05B
Shares Outstanding223.08M
Float210.89M
Cash$609.81M
Debt$1.13B
Short InterestN/A

Institutional Holdings

QoQ: ↓ 1.4% shares (2026Q1 vs prior)
445 institutional holders · 256.17M shares
#1 BlackRock, Inc. 26.34M shares
#2 SUSQUEHANNA INTERNATIONAL GROUP, LLP 25.05M shares
#3 MORGAN STANLEY 20.09M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest62.22M
Days to Cover3.7
% of Float29.5%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
xbrl XBRL CONVERTIBLE 2021-12-31
4 INSIDER TRANSACTION 2026-07-07
4 INSIDER TRANSACTION 2026-06-23
4 INSIDER TRANSACTION 2026-06-23
Full SEC filing analysis available with free account

Recent News

Factual HIMS Dilution Snapshot

Hims & Hers Health, Inc. (HIMS) has a DilutionScore of 17/100, rated Low dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track HIMS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking HIMS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ SPAC / Warrants sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for HIMS
HIMS FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.